Ma Kuang Healthcare Holding Limited (TPEX:4139)
41.00
-0.50 (-1.20%)
Sep 8, 2026, 12:52 PM CST
TPEX:4139 Revenue
Ma Kuang Healthcare Holding had revenue of 277.32M TWD in the quarter ending June 30, 2026, with 1.05% growth. This brings the company's revenue in the last twelve months to 1.09B, down -4.22% year-over-year. In the year 2025, Ma Kuang Healthcare Holding had annual revenue of 1.09B, down -3.34%.
Revenue (ttm)
1.09B
Revenue Growth
-4.22%
P/S Ratio
1.70
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.85B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.09B | -37.75M | -3.34% |
| Dec 31, 2024 | 1.13B | -87.85M | -7.21% |
| Dec 31, 2023 | 1.22B | 159.37M | 15.05% |
| Dec 31, 2022 | 1.06B | 99.29M | 10.35% |
| Dec 31, 2021 | 959.45M | 49.21M | 5.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| BenQ Medical Technology | 5.44B |
| OK Biotech | 1.54B |
| TSH Biopharm Corporation | 1.40B |
| DIVA Laboratories | 894.67M |
| Crystalvue Medical | 874.21M |
| G&E Herbal Biotechnology | 215.61M |
| Gwo Xi Stem Cell Applied Technology Co. , | 157.86M |